SCHEMBL7102817

SCHEMBL7102817

CCOC(=O)C(C(=O)OCC)c1cccc(-c2c(C)ccc(C)c2Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.42
CTSA P10619 6/20 0.41
SMN1; SMN2 Q16637 4/20 0.39
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
GPR35 Q9HC97 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
RAB9A P51151 2/20 0.35
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
KMT2A Q03164 1/20 0.35
GAA P10253 1/20 0.35
ALOX15 P16050 1/20 0.35
GRM6 O15303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812910 0.87 CTSA (0.54) MMP8CTSAGPR35ALDH1A1MAPT
SCHEMBL1274044 0.82 CTSA (0.52) MMP8CTSASMN1; SMN2ALDH1A1MAPT
SCHEMBL9052329 0.77 MMP8 (0.50) MMP8SMN1; SMN2ALDH1A1MAPTRAB9A
SCHEMBL1491141 0.74 MMP8 (0.53) MMP8CA12CA1CA2CA9
SCHEMBL1274836 0.73 MEN1 (0.45) CTSAMAPTKDM4EMEN1KMT2A
SCHEMBL28225086 0.72 MMP8 (0.48) MMP8CA12CA1CA2CA9
SCHEMBL290364 0.71 MMP8 (0.54) MMP8CTSAALDH1A1MAPTHPGD
SCHEMBL20346320 0.71 MMP8 (0.50) MMP8SMN1; SMN2CA12CA1CA2
SCHEMBL29824513 0.71 MMP8 (0.54) MMP8CTSAALDH1A1MAPTHPGD
SCHEMBL15645799 0.71 MMP8 (0.50) MMP8SMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER (DE) 2003-05-22 US disclosed
US-6451843-B1 Arylphenyl-substituted cyclic keto enols BAYER AKTIENGESELLSCHAFT (DE) 2002-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, KCNQ3, SULT1E1 MMP8 4457/4885CTSA 3365/4885SMN1; SMN2 4637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.